ALPHAHELIX MOL.DIAGN. SK1 Cash Flow Conversion Efficiency
ALPHAHELIX MOL.DIAGN. SK1 cash flow conversion efficiency. Based on the latest financial reports, ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€202.00K ≈ $236.16K USD) by net assets (€6.65 Million ≈ $7.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)
Cash flow conversion efficiency of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. This chart illustrates how ALPHAHELIX MOL.DIAGN. SK1's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALPHAHELIX MOL.DIAGN. SK1 stock quote for real-time trading data and today's change.
ALPHAHELIX MOL.DIAGN. SK1 Cash Flow Conversion Ratio Explained
ALPHAHELIX MOL.DIAGN. SK1 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
ALPHAHELIX MOL.DIAGN. SK1 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ALPHAHELIX MOL.DIAGN. SK1 ranked by their cash flow conversion efficiency. Also see ALPHAHELIX MOL.DIAGN. SK1 market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carr's Group plc
LSE:CARR
|
0.075x |
|
GACM Technologies Limited
NSE:GATECHDVR
|
N/A |
|
Topps Tiles PLC
LSE:TPT
|
2.160x |
|
Blockchaink2 Corp
V:BITK
|
0.129x |
|
MAPSPEOPLE A/S DK-02
F:70R
|
N/A |
|
Kooth plc
LSE:KOO
|
0.316x |
|
Internet Gold Golden Lines Ltd
TA:IGLD
|
1.079x |
|
E2Gold Inc
V:ETU
|
0.011x |
Annual Cash Flow Conversion Efficiency for ALPHAHELIX MOL.DIAGN. SK1 (2022–2025)
The table below shows the annual cash flow conversion efficiency of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2025. Review ALPHAHELIX MOL.DIAGN. SK1 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €637.18K ≈ $744.93K |
€820.45K ≈ $959.19K |
1.288x | +220.54% |
| 2024-12-31 | €4.18 Million ≈ $4.88 Million |
€-4.46 Million ≈ $-5.22 Million |
-1.068x | -104.27% |
| 2023-12-31 | €10.41 Million ≈ $12.18 Million |
€-5.45 Million ≈ $-6.37 Million |
-0.523x | -462.81% |
| 2022-12-31 | €19.89 Million ≈ $23.25 Million |
€2.87 Million ≈ $3.35 Million |
0.144x | -- |
About ALPHAHELIX MOL.DIAGN. SK1
Level Bio AB (publ) manufactures and distributes cutting-edge solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (p… Read more